Epidemiology of total serum IgE in a large clinical cohort of subjects with severe or difficult-to-treat asthma

L. Borish, C. M. Dolan, Y. Deniz, B. Zheng (Charlottesville, S. San Francisco, United States Of America)

Source: Annual Congress 2002 - Asthma
Session: Asthma
Session type: Thematic Poster Session
Number: 3200
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Borish, C. M. Dolan, Y. Deniz, B. Zheng (Charlottesville, S. San Francisco, United States Of America). Epidemiology of total serum IgE in a large clinical cohort of subjects with severe or difficult-to-treat asthma. Eur Respir J 2002; 20: Suppl. 38, 3200

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Association of serum IgE level and phadiatop with asthma, rhinitis and smoking in an elderly population from PAQUID cohort
Source: Eur Respir J 2001; 18: Suppl. 33, 436s
Year: 2001

Epidemiology of serum IgE in children with allergic asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 373s
Year: 2001

Monitoring free serum IgE in severe asthma patients treated with omalizumab
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011


Effect of omalizumab on the risk of hospitalisation in patients with uncontrolled severe asthma in real-life. The PAX-LASER cohort
Source: Annual Congress 2010 - Aspects of severe asthma
Year: 2010


Clinical characteristics and burden of illness in a cohort of severe asthma patients
Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life
Year: 2016


Measuring exacerbations in subjects with mild to moderate COPD from a population-based cohort: The CanCOLD study
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013


Characteristics of super-responders to anti IL-5 biologics in a nationwide Danish severe asthma cohort
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021


Characteristics of asthma patients with frequent exacerbations – an observational study in Sweden
Source: International Congress 2017 – Primary care management of asthma and self-management of respiratory disease
Year: 2017

Characteristics and outcomes of chronic cough in individuals with asthma: a population-based study
Source: International Congress 2018 – Asthma and allergy in adults and children and their biomarkers
Year: 2018




Experience with Mepolizumab in a cohort of patients with eosinophilic severe persistent asthma
Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma
Year: 2019


Characteristics of subjects susceptible to exacerbation-like respiratory events in a population-based cohort: Canadian cohort obstructive lung disease (CanCOLD) study
Source: International Congress 2014 – Longitudinal studies of respiratory disease
Year: 2014


Radiologic assed rhinosinusitis, eosinophils and lung function in a population-based cohort of elderly, a comparison of subjects with and without asthma
Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases
Year: 2020

Omalizumab in severe allergic asthma associated with COPD: a multicentric cohort study
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021


A clinically observed variability in serum total IgE in patients being considered for omalizumab therapy
Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action
Year: 2016

Comparison of demographic, functional and inflammatory features between atopic and non atopic asthmatics. Retrospective study on a large cohort of patients.
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020


Effect of tezepelumab on the proportion of exacerbation-free patients with severe, uncontrolled asthma in NAVIGATOR
Source: Virtual Congress 2021 – Clinical trials in airway diseases: novel treatments and new evidence
Year: 2021



The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma
Source: Eur Respir J 2003; 22: 470-477
Year: 2003



Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort
Source: Eur Respir J 2015; 46: 1308-1321
Year: 2015



Characteristics of children with asthma and blood eosinophilia: an observational study
Source: Virtual Congress 2021 – Biomarkers and risk factors in childhood asthma
Year: 2021

The prevalence of subtypes of type-2 inflammation in a real-life population of patients with difficult-to-control asthma
Source: International Congress 2019 – Clinical aspects of airway diseases
Year: 2019